Bicalutamide: all 99 studies that test it
Page 1 of 1. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate CancerRecruitingNCT07783282Phase 1
- Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate CancerNot yet recruitingNCT07593079Phase 2
- Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CTRecruitingNCT07455903Phase 2
- Androgen-responsive POSLUMA-guided Intra-prostatic BoostRecruitingNCT07393867Phase 2
- Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast CancerRecruitingNCT06365788Phase 2
- Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCCRecruitingNCT06222593Phase 1/2
- Bicalutamide Therapy in Young Women With NAFLD and PCOSRecruitingNCT05979389Phase 1
- The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2Not yet recruitingNCT05647356Not applicable
- A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder CancerRecruitingNCT05521698Phase 1
- A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder CancerRecruitingNCT05327647Phase 2
- Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast CancerRecruitingNCT05095207Phase 1/2
- SRT Versus SRT+ADT in Prostate CancerRecruitingNCT05019846Phase 3
- Signal TrAnsduction Pathway Activity Analysis in OVarian cancERRecruitingNCT03458221Phase 2/3
- A Study of Definitive Therapy to Treat Prostate Cancer After ProstatectomyCompletedNCT03043807Phase 2Results posted
- A Study of Definitive Therapy to Treat Prostate CancerCompletedNCT02716974Phase 2Results posted
- Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer PatientsCompletedNCT02614859Phase 2Results posted
- Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate CancerActive, not recruitingNCT01342367Not applicableResults posted
- Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate CancerTerminatedNCT01200810Phase 2Results posted
- Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex® 50 mg Tablet in Healthy Subjects Under Fed ConditionsCompletedNCT01044706Phase 1Results posted
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerCompletedNCT00936390Phase 3Results posted
- Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate CancerTerminatedNCT00924807Phase 1/2Results posted
- Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After CastrationCompletedNCT00878436Phase 1/2Results posted
- Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate CancerCompletedNCT00814788Phase 2Results posted
- CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate CancerTerminatedNCT00702923Phase 1Results posted
- RAD001 and Bicalutamide for Androgen Independent Prostate CancerCompletedNCT00630344Phase 2Results posted
- Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's CycleCompletedNCT00586898Phase 2Results posted
- Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate CancerActive, not recruitingNCT00544830Phase 2Results posted
- Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00486642Phase 2Results posted
- Bicalutamide in Treating Patients With Metastatic Breast CancerCompletedNCT00468715Phase 2Results posted
- External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate CancerTerminatedNCT00388804Phase 3Results posted
- Maximal Suppression of the Androgen Axis in Clinically Localized Prostate CancerCompletedNCT00298155Phase 2Results posted
- Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]CompletedNCT00094328Phase 2Results posted
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00005044Phase 3Results posted
- Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical ProstatectomyCompletedNCT00002874Phase 3Results posted
- A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade GliomaWithdrawnNCT06501911Phase 1
- A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer.WithdrawnNCT06018116Phase 2
- Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialActive, not recruitingNCT05050084Phase 3
- Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate CancerActive, not recruitingNCT04943536Phase 1
- Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialActive, not recruitingNCT04513717Phase 3
- Bicalutamide to Block TMPRSS2 in Males With COVID-19 InfectionWithdrawnNCT04509999Phase 3
- A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate CancerCompletedNCT04284761Phase 1
- Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer PatientsStatus unknownNCT04248621Phase 4
- INTREPId (INTermediate Risk Erection PreservatIon Trial)Active, not recruitingNCT04025372Phase 2
- A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.TerminatedNCT03971110Phase 4
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer PatientsActive, not recruitingNCT03650894Phase 2
- Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryWithdrawnNCT03147196Phase 2
- Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)Status unknownNCT03141671Phase 2
- Ribociclib and Bicalutamide in AR+ TNBCActive, not recruitingNCT03090165Phase 1/2
- Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast CancerTerminatedNCT03055312Phase 3
- Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast CancerStatus unknownNCT02910050Phase 2
- FDHT PET and Bicalutamide in Metastatic Breast CancerCompletedNCT02697032Phase 2
- Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)Active, not recruitingNCT02605486Phase 1/2
- Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation TherapyCompletedNCT02382094Phase 3
- AR-inhibitor Bicalutamide in Treating Patients With TNBCStatus unknownNCT02353988Phase 2
- Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) PatientsTerminatedNCT02348281Phase 2
- High-Dose Brachytherapy in Treating Patients With Prostate CancerCompletedNCT02346253Not applicable
- SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast CancerActive, not recruitingNCT02299999Phase 2
- Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the ProstateCompletedNCT02064036Phase 1
- Androgen Deprivation Therapy in Advanced Salivary Gland CancerCompletedNCT01969578Phase 2
- Degarelix Neo-Adjuvant Radical Prostatectomy TrialCompletedNCT01674270Phase 2
- Oral Mucosal Absorption Study of Bicalutamide New FormulationTerminatedNCT01416883Phase 1
- Bioequivalence of Bicalutamide New Formulation in JapanTerminatedNCT01416870Phase 1
- Oral Mucosal Absorption of ICI176,334-1CompletedNCT01415791Phase 1
- Bioequivalence of ICI176,334-1 in Japanese Healthy Male SubjectsCompletedNCT01415778Phase 1
- Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate CancerCompletedNCT01050842Early Phase 1
- Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting ConditionsCompletedNCT01039233Phase 1
- Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fasting ConditionsCompletedNCT00973050Phase 1
- Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fed ConditionsCompletedNCT00972855Phase 1
- Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed ConditionsCompletedNCT00960310Phase 1
- Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting ConditionsCompletedNCT00959335Phase 1
- Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate CancerCompletedNCT00943956Phase 1
- Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for BrachytherapyCompletedNCT00866554Phase 2
- Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate CancerCompletedNCT00846976Phase 3
- Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation TherapyCompletedNCT00684905Phase 2
- (Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate CancerCompletedNCT00673205Phase 3
- Casodex vs Placebo in Non-Metastatic Early Prostate CancerCompletedNCT00672282Phase 3
- Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate CancerCompletedNCT00657904Phase 3
- Casodex - Nolvadex CombinationCompletedNCT00637871Phase 2
- Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEXCompletedNCT00590213Phase 4
- Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate CancerCompletedNCT00551044Not applicable
- RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local SurgeryCompletedNCT00541047Phase 3
- Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With BicalutamideCompletedNCT00421694Phase 2/3
- Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant TherapyCompletedNCT00418080Phase 2
- Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate CancerCompletedNCT00349557Phase 2
- Casodex/Zoladex Biomarkers in Localised Prostate CancerCompletedNCT00293696Phase 4
- CMAB vs IMAB in Metastatic Prostate CancerWithdrawnNCT00255268Phase 4
- Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized TrialTerminatedNCT00243646Phase 3
- Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy AloneActive, not recruitingNCT00223145Phase 3
- Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical ProstatectomyCompletedNCT00086736Phase 2
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate CancerCompletedNCT00067015Phase 3
- Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate CancerCompletedNCT00031889Phase 2
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerCompletedNCT00030654Phase 3
- Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerCompletedNCT00023829Phase 3
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate CancerCompletedNCT00021450Phase 3
- Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate CancerTerminatedNCT00014586Phase 3
- Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or PeritoneumCompletedNCT00012090Phase 2
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate CancerCompletedNCT00003653Phase 3
- Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate CancerCompletedNCT00002855Phase 3